A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND).
Int J Stroke
; 7(1): 74-80, 2012 Jan.
Article
in En
| MEDLINE
| ID: mdl-22188854
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Thrombolytic Therapy
/
Tissue Plasminogen Activator
/
Stroke
/
Fibrinolytic Agents
Type of study:
Clinical_trials
/
Guideline
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Int J Stroke
Year:
2012
Document type:
Article
Affiliation country:
Australia
Country of publication:
United States